drugset / Trial / NCT01752322

Efficacy and Tolerability of Lidocaine Plaster for Treatment of Long-term Local Nerve Pain

NCT01752322 ↗

Phase 3 Completed 444 enrolled Grünenthal GmbH
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to investigate the efficacy and safety of lidocaine 5% medicated plaster in localized chronic post-operative neuropathic pain in comparison to placebo plaster.

Timeline

Start
2012-10
Primary completion
2016-06
Completion
2016-06

Outcome

Missed primary endpoint

paper but the difference was not statistically significant (-0.23 [0.23], [-0.69, 0.22]). PMID 30614286 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 700 mg Topical